John Laterra
Director, Division of Neuro-Oncology, Johns Hopkins Hospital · Johns Hopkins University School of Medicine
Credentials: · · · ·
History
- Present
Division of Neuro-Oncology · Johns Hopkins University School of Medicine
- 1985–1989
Neurology
- 1980–1984
Doctor of Medicine
Research
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449
Case report · New England Journal of Medicine · 2009 · 822 citations
Amide proton transfer (APT) contrast for imaging of brain tumors
Magnetic Resonance in Medicine · 2003 · 571 citations
Nature Medicine · 2011 · 448 citations
- CE
20 papers
19 papers · 10 as a resident
16 papers
14 papers
- GG
13 papers
13 papers · 4 as a resident
10 papers
- MH
10 papers
Grants
- 2019–2025
Tet2 Regulation and Function in Glioma Cell Phenotype Reprogramming
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.8M · Hugo w. Moser Res Inst Kennedy Krieger
- 2017–2023
Chromatin Modifications in GBM-Propagating Cells
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2.2M · Hugo w. Moser Res Inst Kennedy Krieger
- 2012–2018
Brain Cancer Stem Cell Reprogramming by c-Met
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.8M · Hugo w. Moser Res Inst Kennedy Krieger
- 2011–2017
Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.6M · Hugo w. Moser Res Inst Kennedy Krieger
Clinical trials
- 1999–2004
Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Study chair · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2023–2027
Sub-investigator · Recruiting · Phase 1, Phase 2
SignPath Pharma, Inc.